141 related articles for article (PubMed ID: 18647961)
1. Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers.
Beadle G; Baade P; Fritschi L
Ann Oncol; 2009 Jan; 20(1):103-9. PubMed ID: 18647961
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
Kaplan HG; Malmgren JA; Atwood MK
BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
[TBL] [Abstract][Full Text] [Related]
3. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
[TBL] [Abstract][Full Text] [Related]
4. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
Kaplan H; Malmgren J; De Roos AJ
Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
[TBL] [Abstract][Full Text] [Related]
5. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K
Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
Kröger N; Zander AR; Martinelli G; Ferrante P; Moraleda JM; Da Prada GA; Demirer T; Socie G; Rosti G;
Ann Oncol; 2003 Apr; 14(4):554-8. PubMed ID: 12649100
[TBL] [Abstract][Full Text] [Related]
7. Secondary hematological malignancies after treatment of non-metastatic breast cancer.
Arslan C; Ozdemir E; Dogan E; Ozisik Y; Altundag K
J BUON; 2011; 16(4):744-50. PubMed ID: 22331732
[TBL] [Abstract][Full Text] [Related]
8. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.
Kaplan HG; Malmgren JA; Li CI; Calip GS
Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034
[TBL] [Abstract][Full Text] [Related]
9. Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
Int J Cancer; 2021 Jan; 148(2):375-384. PubMed ID: 32683691
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study.
Brown CA; Youlden DR; Aitken JF; Moore AS
Pediatr Blood Cancer; 2018 Dec; 65(12):e27410. PubMed ID: 30183136
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.
Patt DA; Duan Z; Fang S; Hortobagyi GN; Giordano SH
J Clin Oncol; 2007 Sep; 25(25):3871-6. PubMed ID: 17664457
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy.
Lee JW; Oh H; You JY; Lee ES; Lee JH; Song SE; Lee NK; Jung SP; An JS; Cho KR; Kim CY; Park KH
Eur J Cancer; 2023 Sep; 191():112952. PubMed ID: 37473463
[TBL] [Abstract][Full Text] [Related]
13. Late effects of adjuvant therapy for breast cancer.
Shapiro CL; Recht A
J Natl Cancer Inst Monogr; 1994; (16):101-12. PubMed ID: 7999452
[No Abstract] [Full Text] [Related]
14. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
15. Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study.
Martin MG; Welch JS; Luo J; Ellis MJ; Graubert TA; Walter MJ
Breast Cancer Res Treat; 2009 Dec; 118(3):593-8. PubMed ID: 19322652
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
Smith RE; Bryant J; DeCillis A; Anderson S;
J Clin Oncol; 2003 Apr; 21(7):1195-204. PubMed ID: 12663705
[TBL] [Abstract][Full Text] [Related]
17. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
Calip GS; Law EH; Ko NY
Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645
[TBL] [Abstract][Full Text] [Related]
18. Leukemia incidence following primary breast carcinoma treatment.
Kaplan HG; Malmgren JA; Atwood M
Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
[TBL] [Abstract][Full Text] [Related]
19. Second primary malignancies in adult acute myeloid leukemia--A US population-based study.
Ghimire KB; Shah BK
Anticancer Res; 2014 Jul; 34(7):3855-9. PubMed ID: 24982414
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML.
de Nully Brown P; Hoffmann T; Hansen OP; Boesen AM; Grønbaek K; Hippe E; Jensen MK; Thorling K; Storm HH; Pedersen-Bjergaard J
Leukemia; 1997 Jan; 11(1):37-41. PubMed ID: 9001416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
